Use of epidermal growth factor receptor mutation analysis in patients with advanced non-small-cell lung cancer to determine erlotinib use as first-line therapy by Ishibe Naoko, Carlson Josh, Ramsey Scott David, Freedman Andrew, Schully Sheri in PLoS currents (2011).

[PMID: 21743846] PubMed


Discussed In Paper


Rx Annotations

No dosing information annotated.